JAMA Network
Rebecca T. Emeny, PhD, MPH; Chiang-Hua Chang, PhD; Jonathan Skinner, PhD; A. James O’Malley, PhD; Jeremy Smith, MPH; Gouri Chakraborti, MA; Clifford J. Rosen, MD; Nancy E. Morden, MD, MPH
Manyprescriptiondrugsincreasefracturerisk,whichraisesconcernforpatients receiving 2 or more such drugs concurrently. Logic suggests that risk will increase with each additional drug, but the risk of taking multiple fracture-associated drugs (FADs) is unknown.
ToestimatehipfractureriskassociatedwithconcurrentexposuretomultipleFADs.